CVS' Combat Meth Compliance Failings Could Fuel PSE Rx-Only Movement

A lapse in CVS' tracking of methamphetamine precursor purchases cost the drugstore chain $75 million in civil penalties and could bolster arguments that pseudoephedrine should be available by prescription only